COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05047718


Column Value
Trial registration number NCT05047718
Full text link
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Oct. 6, 2022, 8 a.m.
Source : ClinicalTrials.gov

Not reported

Contact
Last imported at : Oct. 6, 2022, 8 a.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

2021-09-17

Recruitment status
Last imported at : April 19, 2023, noon
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

nonRCT

Allocation
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Non-randomized

Design
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Prevention

Inclusion criteria
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

inclusion criteria: - for the group with a past history of covid-19 (convalescents)= subject within ≥ 3 months after infection - for the no past history of covid-19 (naives), subject with no known history of covid-19 - patient affiliated or entitled to a social security plan - patients who have received informed information about the study and who have co-signed a consent to participate in the study with the investigator

Exclusion criteria
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

- immunocompromised or under immunosuppressive treatment - subject with a history of covid hospitalized in intensive care - subject allergic to one of the components of the vaccines used in the study - subject vaccinated for covid-19 - subject with persistent symptoms of covid-19 (long covid) - subjects with unstable chronic pathology - persons deprived of liberty, hospitalized without consent - pregnant or breastfeeding woman

Number of arms
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

4

Funding
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Centre Hospitalier Universitaire de Saint Etienne

Inclusion age min
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

France

Type of patients
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Healthy volunteers

Severity scale
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Oct. 6, 2022, 8 a.m.
Source : ClinicalTrials.gov

54

primary outcome
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Anti-S neutralizing antibody titer

Notes
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

Phase 4

Arms
Last imported at : Sept. 21, 2021, 5:30 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "Healthy volunteers;2", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Infected patients;1", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Healthy volunteers;2", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Infected patients;1", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]